Acetaminophen, the Active Ingredient of Tylenol, Protects against Peroxynitrite-Induced DNA Damage: A Chemiluminometric and Electron Paramagnetic Resonance Spectrometric Study
Keywords:
Acetaminophen, Chemiluminometry, DNA damage, Electron paramagnetic resonance, Peroxynitrite, SIN-1, Spin-trappingAbstract
This study investigated the hypothesis that acetaminophen at pharmacologically relevant concentrations may act as a protector against peroxynitrite toxicity. Our results showed that acetaminophen inhibited SIN-1 (a peroxynitrite generator)-induced DNA cleavage in a concentration-dependent manner in an in vitro model. With bicarbonate-enhanced luminol-dependent chemiluminometry, we further showed a nearly complete blockage of peroxynitrite-derived chemiluminescence by acetaminophen at 25‒100 µM with minimal effects on SIN-1-mediated oxygen consumption, suggesting acetaminophen as a potent scavenger of peroxynitrite. Electron spin resonance spectrometry in combination with 5,5-dimethyl-1-pyrroline N-oxide (DMPO)-spin-trapping supported the ability of acetaminophen at high concentrations to diminish the production of a free radical species (likely hydroxyl radical) from SIN-1. Fenton chemistry-based DMPO-spin trapping further demonstrated the hydroxyl radical-scavenging capacity of acetaminophen. Collectively, the results of this study for the first time revealed the potential of acetaminophen to protect against peroxyitrite toxicity, which may have important implications in neuroprotection associated with the use of this popular analgesic and antipyretic drug.
Downloads
Published
How to Cite
Issue
Section
License
Submission of an original manuscript to the Journal will be taken to mean that it represents original work not previously published; that it is not being considered elsewhere for publication; that the author(s) agrees to assign copyright to the Journal upon acceptance for publication in the Journal, and if accepted for publication, it will be published in the digital format (PDF) and/or in print and it will not be published elsewhere in the same form, for commercial purposes, in any language, without the consent of the Publisher.